Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Postovsky, S; Beck, D; Ben-Izhak, O; Ben Arush, MW
   Secondary thyroid carcinoma after treatment for clear cell carcinoma of the uterus: Case report and review of the literature
   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
   
   S. Postovsky et al., "Secondary thyroid carcinoma after treatment for clear cell carcinoma of the uterus: Case report and review of the literature", J PED H ONC, 23(4), 2001, pp. 257-258
2. Honma, Y
   A novel therapeutic strategy against monocytic leukemia with deoxyadenosine analogs and adenosine deaminase inhibitors
   LEUKEMIA & LYMPHOMA
   
   Y. Honma, "A novel therapeutic strategy against monocytic leukemia with deoxyadenosine analogs and adenosine deaminase inhibitors", LEUK LYMPH, 42(5), 2001, pp. 953-962
3. Exner, M; Thalhammer-Scherrer, R; Kudlacek, S; Simonitsch, I; Jager, U; Schwarzinger, I
   Suspect cell convolutes in the bone marrow of a patient with renal cell carcinoma unmasked as atypical convolutes of hairy cells
   LEUKEMIA & LYMPHOMA
   
   M. Exner et al., "Suspect cell convolutes in the bone marrow of a patient with renal cell carcinoma unmasked as atypical convolutes of hairy cells", LEUK LYMPH, 42(1-2), 2001, pp. 239-241
4. Nakamura, T; Ohno, M; Tabuchi, Y; Kamigaki, T; Fujii, H; Yamagishi, H; Kuroda, Y
   Optimal duration of oral adjuvant chemotherapy with Carmofur in the colorectal cancer patients: the Kansai Carmofur Study Group trial III
   INTERNATIONAL JOURNAL OF ONCOLOGY
   
   T. Nakamura et al., "Optimal duration of oral adjuvant chemotherapy with Carmofur in the colorectal cancer patients: the Kansai Carmofur Study Group trial III", INT J ONCOL, 19(2), 2001, pp. 291-298
5. Bergfeldt, K; Nilsson, B; Einhorn, S; Hall, P
   Breast cancer risk in women with a primary ovarian cancer - a case-controlstudy
   EUROPEAN JOURNAL OF CANCER
   
   K. Bergfeldt et al., "Breast cancer risk in women with a primary ovarian cancer - a case-controlstudy", EUR J CANC, 37(17), 2001, pp. 2229-2234
6. Paulussen, M; Ahrens, S; Lehnert, M; Taeger, D; Hense, HW; Wagner, A; Dunst, J; Harms, D; Reiter, A; Henze, G; Niemeyer, C; Gobel, U; Kremens, B; Folsch, UR; Aulitzky, WE; Voute, PA; Zoubek, A; Jurgens, H
   Second malignancies after Ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study
   ANNALS OF ONCOLOGY
   
   M. Paulussen et al., "Second malignancies after Ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study", ANN ONCOL, 12(11), 2001, pp. 1619-1630
7. Andrey, J; Saven, A
   Therapeutic advances in the treatment of hairy cell leukemia
   LEUKEMIA RESEARCH
   
   J. Andrey e A. Saven, "Therapeutic advances in the treatment of hairy cell leukemia", LEUK RES, 25(5), 2001, pp. 361-368
8. Leung, W; Sandlund, JT; Hudson, MM; Zhou, YM; Hancock, ML; Zhu, YP; Ribeiro, RC; Rubnitz, JE; Kun, LE; Razzouk, B; Evans, WE; Pui, CH
   Second malignancy after treatment of childhood non-Hodgkin lymphoma
   CANCER
   
   W. Leung et al., "Second malignancy after treatment of childhood non-Hodgkin lymphoma", CANCER, 92(7), 2001, pp. 1959-1966
9. Merimsky, O; Kollender, Y; Issakov, J; Bickels, J; Flusser, G; Gutman, M; Lev-Chelouche, P; Inbar, M; Meller, I
   Multiple primary malignancies in association with soft tissue sarcomas
   CANCER
   
   O. Merimsky et al., "Multiple primary malignancies in association with soft tissue sarcomas", CANCER, 91(7), 2001, pp. 1363-1371
10. Rueffer, U; Josting, A; Franklin, J; May, M; Sieber, M; Breuer, K; Engert, A; Diehl, V
    Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: Incidence, treatment, and prognosis
    JOURNAL OF CLINICAL ONCOLOGY
    
    U. Rueffer et al., "Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: Incidence, treatment, and prognosis", J CL ONCOL, 19(7), 2000, pp. 2026-2032
11. Green, DM; Hyland, A; Barcos, MP; Reynolds, JA; Lee, RJ; Hall, BC; Zevon, MA
    Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence
    JOURNAL OF CLINICAL ONCOLOGY
    
    D.M. Green et al., "Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence", J CL ONCOL, 18(7), 2000, pp. 1492-1499
12. Micallef, INM; Lillington, DM; Apostolidis, J; Amess, JAL; Neat, M; Matthews, J; Clark, T; Foran, JM; Salam, A; Lister, TA; Rohatiner, AZS
    Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell supportfor lymphoid malignancies
    JOURNAL OF CLINICAL ONCOLOGY
    
    I.N.M. Micallef et al., "Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell supportfor lymphoid malignancies", J CL ONCOL, 18(5), 2000, pp. 947-955
13. Socie, G; Curtis, RE; Deeg, HJ; Sobocinski, KA; Filipovich, AH; Travis, LB; Sullivan, KM; Rowlings, PA; Kingma, DW; Banks, PM; Travis, WD; Witherspoon, RP; Sanders, J; Jaffe, ES; Horowitz, MM
    New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia
    JOURNAL OF CLINICAL ONCOLOGY
    
    G. Socie et al., "New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia", J CL ONCOL, 18(2), 2000, pp. 348-357
14. Zinzani, PL; Magagnoli, M; Bendandi, M; Tani, M; Stefoni, V; Cellini, C; Poggi, S; Piccioli, M; Pileri, S; Tura, S
    Long-term follow-up of hairy cell leukemia patients treated with 2-chlorodeoxyadenosine
    HAEMATOLOGICA
    
    P.L. Zinzani et al., "Long-term follow-up of hairy cell leukemia patients treated with 2-chlorodeoxyadenosine", HAEMATOLOG, 85(9), 2000, pp. 922-925
15. Grutzner, S; Aydemir, U; Schmidt, M; Holzel, D; Hiller, E; Munker, R
    Risk of basal cell carcinoma after Hodgkin's disease
    ONKOLOGIE
    
    S. Grutzner et al., "Risk of basal cell carcinoma after Hodgkin's disease", ONKOLOGIE, 23(2), 2000, pp. 169-171
16. Deutsch, M; Jacobs, SA
    Kaposi sarcoma after treatment of Hodgkin's disease in a young adult Non-AIDS patient - Case report and review
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    
    M. Deutsch e S.A. Jacobs, "Kaposi sarcoma after treatment of Hodgkin's disease in a young adult Non-AIDS patient - Case report and review", AM J CL ONC, 23(1), 2000, pp. 26-28
17. Ammon, J
    Secondary tumorigenesis after radiotherapy
    SECONDARY NEOPLASIAS FOLLOWING CHEMOTHERAPY, RADIOTHERAPY, AND IMMUNOSUPPRESSION
    
    J. Ammon, "Secondary tumorigenesis after radiotherapy", CONTR ONCOL, 55, 2000, pp. 147-164
18. Langner, K; Muller, KM; Junker, K
    Changing differentiation in small-cell lung cancer after chemotherapy
    PATHOLOGE
    
    K. Langner et al., "Changing differentiation in small-cell lung cancer after chemotherapy", PATHOLOGE, 21(5), 2000, pp. 358-363
19. Garwicz, S; Anderson, H; Olsen, JH; Dollner, H; Hertz, H; Jonmundsson, G; Langmark, F; Lanning, M; Moller, T; Sankila, R; Tulinius, H
    Second malignant neoplasms after cancer in childhood and adolescence: A population-based case-control study in the 5 Nordic countries
    INTERNATIONAL JOURNAL OF CANCER
    
    S. Garwicz et al., "Second malignant neoplasms after cancer in childhood and adolescence: A population-based case-control study in the 5 Nordic countries", INT J CANC, 88(4), 2000, pp. 672-678
20. Brenner, DJ; Curtis, RE; Hall, EJ; Ron, E
    Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery
    CANCER
    
    D.J. Brenner et al., "Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery", CANCER, 88(2), 2000, pp. 398-406
21. Nessling, M; Solinas-Toldo, S; Lichter, P; Reifenberger, G; Wolter, M; Moller, P; Dohner, H; Bentz, M
    Genomic imbalances are rare in hairy cell leukemia
    GENES CHROMOSOMES & CANCER
    
    M. Nessling et al., "Genomic imbalances are rare in hairy cell leukemia", GENE CHROM, 26(2), 1999, pp. 182-183
22. Riquet, M; Barthes, FL; Chehab, A; Danel, C
    Adenosquamous carcinoma occurring after small cell lung cancer: a 10 year follow-up
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
    
    M. Riquet et al., "Adenosquamous carcinoma occurring after small cell lung cancer: a 10 year follow-up", EUR J CAR-T, 16(3), 1999, pp. 384-386
23. Deutsch, M; Rosenstein, MM; Ramanathan, RK
    Pancreatic cancer in a young adult after treatment for Hodgkin's disease
    CLINICAL ONCOLOGY
    
    M. Deutsch et al., "Pancreatic cancer in a young adult after treatment for Hodgkin's disease", CL ONCOL-UK, 11(4), 1999, pp. 280-282
24. Cheson, BD; Vena, DA; Barrett, J; Freidlin, B
    Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias
    JOURNAL OF CLINICAL ONCOLOGY
    
    B.D. Cheson et al., "Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias", J CL ONCOL, 17(8), 1999, pp. 2454-2460
25. Shah, AB; Hudson, MM; Poquette, CA; Luo, XL; Wilimas, JA; Kun, LE
    Long-term follow-up of patients treated with primary radiotherapy for supradiaphragmatic Hodgkin's disease at St. Jude Children's Research Hospital
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    
    A.B. Shah et al., "Long-term follow-up of patients treated with primary radiotherapy for supradiaphragmatic Hodgkin's disease at St. Jude Children's Research Hospital", INT J RAD O, 44(4), 1999, pp. 867-877
26. Nio, Y; Hirahara, N; Minari, Y; Sasaki, S; Takamura, M; Sato, Y; Inoue, Y; Nagami, H; Tamura, K
    Second malignancies after a gastrectomy for gastric cancers: The effects of adjuvant therapies
    ANTICANCER RESEARCH
    
    Y. Nio et al., "Second malignancies after a gastrectomy for gastric cancers: The effects of adjuvant therapies", ANTICANC R, 19(4C), 1999, pp. 3591-3599
27. Gervais-Fagnou, DD; Girouard, C; Laperriere, N; Pintillie, M; Goss, PE
    Breast cancer in women following supradiaphragmatic irradiation for Hodgkin's disease
    ONCOLOGY
    
    D.D. Gervais-Fagnou et al., "Breast cancer in women following supradiaphragmatic irradiation for Hodgkin's disease", ONCOL-BASEL, 57(3), 1999, pp. 224-231
28. Gafanovich, A; Ramu, N; Krichevsky, S; Pe'er, J; Amir, G; Ben-Yehuda, D
    Microsatellite instability and p53 mutations in pediatric secondary malignant neoplasms
    CANCER
    
    A. Gafanovich et al., "Microsatellite instability and p53 mutations in pediatric secondary malignant neoplasms", CANCER, 85(2), 1999, pp. 504-510
29. TROUSSARD X; MALOISEL F; FLANDRIN G
    HAIRY-CELL LEUKEMIA - WHAT IS NEW 40 YEARS AFTER THE FIRST DESCRIPTION
    HEMATOLOGY AND CELL THERAPY
    
    X. Troussard et al., "HAIRY-CELL LEUKEMIA - WHAT IS NEW 40 YEARS AFTER THE FIRST DESCRIPTION", HEM CELL TH, 40(4), 1998, pp. 139-148
30. STROM SS; GU Y; SIGURDSON AJ; BAILEY NM; AMOS CI; SPITZ MR; RODRIGUEZ MA; LIANG JC
    CHROMOSOME BREAKS AND SISTER-CHROMATID EXCHANGE AS PREDICTORS OF 2ND CANCERS IN HODGKINS-DISEASE
    Leukemia & lymphoma
    
    S.S. Strom et al., "CHROMOSOME BREAKS AND SISTER-CHROMATID EXCHANGE AS PREDICTORS OF 2ND CANCERS IN HODGKINS-DISEASE", Leukemia & lymphoma, 28(5-6), 1998, pp. 561-566
31. Canellos, GP
    Treatment of relapsed Hodgkin's disease: Strategies and prognostic factors
    ANNALS OF ONCOLOGY
    
    G.P. Canellos, "Treatment of relapsed Hodgkin's disease: Strategies and prognostic factors", ANN ONCOL, 9, 1998, pp. 91-96
32. COMIS RL; FRIEDLAND DM; GOOD BC
    SMALL-CELL LUNG-CANCER - A PERSPECTIVE ON THE PAST AND A PREVIEW OF THE FUTURE
    Oncology
    
    R.L. Comis et al., "SMALL-CELL LUNG-CANCER - A PERSPECTIVE ON THE PAST AND A PREVIEW OF THE FUTURE", Oncology, 12(1), 1998, pp. 44-50
33. LOEFFLER M; BROSTEANU O; HASENCLEVER D; SEXTRO M; ASSOULINE D; BARTOLUCCI AA; CASSILETH PA; CROWTHER D; DIEHL V; FISHER RI; HOPPE RT; JACOBS P; PATER JL; PAVLOVSKY S; THOMPSON E; WIERNIK P
    METAANALYSIS OF CHEMOTHERAPY VERSUS COMBINED-MODALITY TREATMENT TRIALS IN HODGKINS-DISEASE
    Journal of clinical oncology
    
    M. Loeffler et al., "METAANALYSIS OF CHEMOTHERAPY VERSUS COMBINED-MODALITY TREATMENT TRIALS IN HODGKINS-DISEASE", Journal of clinical oncology, 16(3), 1998, pp. 818-829
34. ENRICI RM; ANSELMO AP; IACARI V; OSTI MF; SANTORO M; TOMBOLINI V; MANDELLI F; BIAGINI C
    THE RISK OF NON-HODGKINS-LYMPHOMA AFTER HODGKINS-DISEASE, WITH SPECIAL REFERENCE TO SPLENIC TREATMENT
    Haematologica
    
    R.M. Enrici et al., "THE RISK OF NON-HODGKINS-LYMPHOMA AFTER HODGKINS-DISEASE, WITH SPECIAL REFERENCE TO SPLENIC TREATMENT", Haematologica, 83(7), 1998, pp. 636-644
35. KOLLMANNSBERGER C; HARTMANN JT; KANZ L; BOKEMEYER C
    RISK OF SECONDARY MYELOID-LEUKEMIA AND MYELODYSPLASTIC SYNDROME FOLLOWING STANDARD-DOSE CHEMOTHERAPY OR HIGH-DOSE CHEMOTHERAPY WITH STEM-CELL SUPPORT IN PATIENTS WITH POTENTIALLY CURABLE MALIGNANCIES
    Journal of cancer research and clinical oncology
    
    C. Kollmannsberger et al., "RISK OF SECONDARY MYELOID-LEUKEMIA AND MYELODYSPLASTIC SYNDROME FOLLOWING STANDARD-DOSE CHEMOTHERAPY OR HIGH-DOSE CHEMOTHERAPY WITH STEM-CELL SUPPORT IN PATIENTS WITH POTENTIALLY CURABLE MALIGNANCIES", Journal of cancer research and clinical oncology, 124(3-4), 1998, pp. 207-214
36. SIEGERT E; WEISSBACH G; FISCHER R; LAUTERBACH I
    NON-HODGKIN-LYMPHOMA (NHL) AS A 2ND NEOPLASM OCCURRING AFTER NEUROBLASTOMA TREATMENT
    Medical and pediatric oncology
    
    E. Siegert et al., "NON-HODGKIN-LYMPHOMA (NHL) AS A 2ND NEOPLASM OCCURRING AFTER NEUROBLASTOMA TREATMENT", Medical and pediatric oncology, 30(1), 1998, pp. 18-21
37. Ranaghan, L; Markey, GM; Morris, TCM
    Outcome in Hodgkin's disease: A 20-year cohort of patients
    ULSTER MEDICAL JOURNAL
    
    L. Ranaghan et al., "Outcome in Hodgkin's disease: A 20-year cohort of patients", ULSTER MED, 67(2), 1998, pp. 91-98
38. VLACHAKI MT; HA CS; HAGEMEISTER FB; FULLER LM; RODRIGUEZ MA; HESS MA; TUCKER SL; CABANILLAS F; COX JD
    STAGE-I HODGKIN DISEASE - RADIATION-THERAPY AND CHEMOTHERAPY AT THE UNIVERSITY-OF-TEXAS M.D.-ANDERSON-CANCER-CENTER, 1967-1997
    Radiology
    
    M.T. Vlachaki et al., "STAGE-I HODGKIN DISEASE - RADIATION-THERAPY AND CHEMOTHERAPY AT THE UNIVERSITY-OF-TEXAS M.D.-ANDERSON-CANCER-CENTER, 1967-1997", Radiology, 208(3), 1998, pp. 739-747
39. TSUKASAKI K; KOBA T; IWANAGA M; MURATA K; MAEDA T; ATOGAMI S; NAKAMURA H; YAMADA Y; KAMIHIRA S; TOMONAGA M
    POSSIBLE ASSOCIATION BETWEEN ADULT T-CELL LEUKEMIA LYMPHOMA AND ACUTEMYELOID-LEUKEMIA/
    Cancer
    
    K. Tsukasaki et al., "POSSIBLE ASSOCIATION BETWEEN ADULT T-CELL LEUKEMIA LYMPHOMA AND ACUTEMYELOID-LEUKEMIA/", Cancer, 82(3), 1998, pp. 488-494
40. AU WY; KLASA RJ; GALLAGHER R; LE N; GASCOYNE RD; CONNORS JM
    2ND MALIGNANCIES IN PATIENTS WITH HAIRY-CELL LEUKEMIA IN BRITISH-COLUMBIA - A 20-YEAR EXPERIENCE
    Blood
    
    W.Y. Au et al., "2ND MALIGNANCIES IN PATIENTS WITH HAIRY-CELL LEUKEMIA IN BRITISH-COLUMBIA - A 20-YEAR EXPERIENCE", Blood, 92(4), 1998, pp. 1160-1164
41. PETERSEN RW; MCCARTNEY AJ
    HIGH-GRADE BORDERLINE TUMOR IN A TRANSPOSED OVARY FOLLOWING TREATMENTOF CERVICAL-CARCINOMA
    Australian and New Zealand Journal of Obstetrics and Gynaecology
    
    R.W. Petersen e A.J. Mccartney, "HIGH-GRADE BORDERLINE TUMOR IN A TRANSPOSED OVARY FOLLOWING TREATMENTOF CERVICAL-CARCINOMA", Australian and New Zealand Journal of Obstetrics and Gynaecology, 38(1), 1998, pp. 121-123
42. BAROSI G; AMBROSETTI A; CENTRA A; FALCONE A; FINELLI C; FOA P; GROSSI A; GUARNONE R; RUPOLI S; LUCIANO L; PETTI MC; POGLIANI E; RUSSO D; RUGGERI M; QUAGLINI S
    SPLENECTOMY AND RISK OF BLAST-TRANSFORMATION IN MYELOFIBROSIS WITH MYELOID METAPLASIA
    Blood
    
    G. Barosi et al., "SPLENECTOMY AND RISK OF BLAST-TRANSFORMATION IN MYELOFIBROSIS WITH MYELOID METAPLASIA", Blood, 91(10), 1998, pp. 3630-3636
43. CARAWAY NP; WOJCIK EM; SABOORIAN HM; KATZ RL
    CONCOMITANT LYMPHOMA AND METASTATIC CARCINOMA IN A LYMPH-NODE - DIAGNOSIS BY FINE-NEEDLE ASPIRATION BIOPSY IN 2 CASES
    Diagnostic cytopathology
    
    N.P. Caraway et al., "CONCOMITANT LYMPHOMA AND METASTATIC CARCINOMA IN A LYMPH-NODE - DIAGNOSIS BY FINE-NEEDLE ASPIRATION BIOPSY IN 2 CASES", Diagnostic cytopathology, 17(4), 1997, pp. 287-291
44. WANDERAS EH; FOSSA SD; TRETLI S
    RISK OF SUBSEQUENT NON-GERM CELL-CANCER AFTER TREATMENT OF GERM-CELL CANCER IN 2006 NORWEGIAN MALE-PATIENTS
    European journal of cancer
    
    E.H. Wanderas et al., "RISK OF SUBSEQUENT NON-GERM CELL-CANCER AFTER TREATMENT OF GERM-CELL CANCER IN 2006 NORWEGIAN MALE-PATIENTS", European journal of cancer, 33(2), 1997, pp. 253-262
45. CUTULI B; DHERMAIN F; BOREL C; DELAROCHEFORDIERE A; GRAIC Y; DELAFONTAN B; DILHYUDY JM; MIGNOTTE H; TESSIER E; TORTOCHAUX J; NGUYEN T; BEY P; LEMEVELLEPOURHIET A; VELTEN M; ARRIAGADA R
    BREAST-CANCER IN PATIENTS TREATED FOR HODGKINS-DISEASE - CLINICAL ANDPATHOLOGICAL ANALYSIS OF 76 CASES IN 63 PATIENTS
    European journal of cancer
    
    B. Cutuli et al., "BREAST-CANCER IN PATIENTS TREATED FOR HODGKINS-DISEASE - CLINICAL ANDPATHOLOGICAL ANALYSIS OF 76 CASES IN 63 PATIENTS", European journal of cancer, 33(14), 1997, pp. 2315-2320
46. RIPLEY D; WEINERMAN BH
    INCREASED INCIDENCE OF 2ND MALIGNANCIES ASSOCIATED WITH SMALL-BOWEL ADENOCARCINOMA
    Canadian journal of gastroenterology
    
    D. Ripley e B.H. Weinerman, "INCREASED INCIDENCE OF 2ND MALIGNANCIES ASSOCIATED WITH SMALL-BOWEL ADENOCARCINOMA", Canadian journal of gastroenterology, 11(1), 1997, pp. 65-68
47. VLACHAKI MT; HA CS; HAGEMEISTER FB; FULLER LM; RODRIGUEZ MA; BESA PC; HESS MA; BROWN B; CABANILLAS F; COX JD
    LONG-TERM OUTCOME OF TREATMENT FOR ANN-ARBOR STAGE-1 HODGKINS-DISEASE- PATTERNS OF FAILURE, LATE TOXICITY AND 2ND MALIGNANCIES
    International journal of radiation oncology, biology, physics
    
    M.T. Vlachaki et al., "LONG-TERM OUTCOME OF TREATMENT FOR ANN-ARBOR STAGE-1 HODGKINS-DISEASE- PATTERNS OF FAILURE, LATE TOXICITY AND 2ND MALIGNANCIES", International journal of radiation oncology, biology, physics, 39(3), 1997, pp. 609-616
48. FOLLOWILL D; GEIS P; BOYER A
    ESTIMATES OF WHOLE-BODY DOSE-EQUIVALENT PRODUCED BY BEAM INTENSITY-MODULATED CONFORMAL THERAPY
    International journal of radiation oncology, biology, physics
    
    D. Followill et al., "ESTIMATES OF WHOLE-BODY DOSE-EQUIVALENT PRODUCED BY BEAM INTENSITY-MODULATED CONFORMAL THERAPY", International journal of radiation oncology, biology, physics, 38(3), 1997, pp. 667-672
49. TINGER A; WASSERMAN TH; KLEIN EE; MILLER EA; ROBERTS T; PIEPHOFF JV; KUCIK NA
    THE INCIDENCE OF BREAST-CANCER FOLLOWING MANTLE FIELD RADIATION-THERAPY AS A FUNCTION OF DOSE AND TECHNIQUE
    International journal of radiation oncology, biology, physics
    
    A. Tinger et al., "THE INCIDENCE OF BREAST-CANCER FOLLOWING MANTLE FIELD RADIATION-THERAPY AS A FUNCTION OF DOSE AND TECHNIQUE", International journal of radiation oncology, biology, physics, 37(4), 1997, pp. 865-870
50. GRAU JJ; CUCHI A; TRASERRA J; FIRVIDA JL; ARIAS C; BLANCH JL; ESTAPE J
    FOLLOW-UP-STUDY IN HEAD AND NECK-CANCER - CURE RATE ACCORDING TO TUMOR LOCATION AND STAGE
    Oncology
    
    J.J. Grau et al., "FOLLOW-UP-STUDY IN HEAD AND NECK-CANCER - CURE RATE ACCORDING TO TUMOR LOCATION AND STAGE", Oncology, 54(1), 1997, pp. 38-42
51. KRIKORIAN JG; PALMERTOY DE; CAREY RW; HOCK H
    INFLAMMATION OF THE EARS, ANEMIA, AND FEVER 21 YEARS AFTER TREATMENT FOR HODGKINS-DISEASE - ACUTE ERYTHROLEUKEMIA (CHEMOTHERAPY-RELATED) - HODGKINS-DISEASE, TREATED (RELAPSING POLYCHONDRITIS)
    The New England journal of medicine
    
    J.G. Krikorian et al., "INFLAMMATION OF THE EARS, ANEMIA, AND FEVER 21 YEARS AFTER TREATMENT FOR HODGKINS-DISEASE - ACUTE ERYTHROLEUKEMIA (CHEMOTHERAPY-RELATED) - HODGKINS-DISEASE, TREATED (RELAPSING POLYCHONDRITIS)", The New England journal of medicine, 337(24), 1997, pp. 1753-1760
52. HJALGRIM H; FRISCH M; PUKKALA E; TULINIUS H; EKBOM A; DICTOR M; LANGMARK F; HARDARSON S; MELBYE M
    RISK OF 2ND CANCERS IN CLASSICAL KAPOSIS-SARCOMA
    International journal of cancer
    
    H. Hjalgrim et al., "RISK OF 2ND CANCERS IN CLASSICAL KAPOSIS-SARCOMA", International journal of cancer, 73(6), 1997, pp. 840-843
53. SORIA JC; BRECHOT JM; LEBEAU B; ROCHEMAURE J
    2ND PRIMARY MALIGNANCIES AFTER SMALL-CELLLUNG-CANCER
    Bulletin du cancer
    
    J.C. Soria et al., "2ND PRIMARY MALIGNANCIES AFTER SMALL-CELLLUNG-CANCER", Bulletin du cancer, 84(8), 1997, pp. 800-806
54. MOTTOLESE M; VENTURO I; RINALDI M; LOPEZ M; BIGOTTI G; BENEVOLO M; NATALI PG
    IDENTIFICATION OF 2ND MALIGNANCIES ON EFFUSIONS AND FINE-NEEDLE ASPIRATES USING A PANEL OF MONOCLONAL-ANTIBODIES
    British Journal of Cancer
    
    M. Mottolese et al., "IDENTIFICATION OF 2ND MALIGNANCIES ON EFFUSIONS AND FINE-NEEDLE ASPIRATES USING A PANEL OF MONOCLONAL-ANTIBODIES", British Journal of Cancer, 75(4), 1997, pp. 572-578
55. TUCKER MA; MURRAY N; SHAW EG; ETTINGER DS; MABRY M; HUBER MH; FELD R; SHEPHERD FA; JOHNSON DH; GRANT SC; AISNER J; JOHNSON BE
    2ND PRIMARY CANCERS RELATED TO SMOKING AND TREATMENT OF SMALL-CELL LUNG-CANCER
    Journal of the National Cancer Institute
    
    M.A. Tucker et al., "2ND PRIMARY CANCERS RELATED TO SMOKING AND TREATMENT OF SMALL-CELL LUNG-CANCER", Journal of the National Cancer Institute, 89(23), 1997, pp. 1782-1788
56. TRAVIS LB; CURTIS RE; STORM H; HALL P; HOLOWATY E; VANLEEUWEN FE; KOHLER BA; PUKKALA E; LYNCH CF; ANDERSSON M; BERGFELDT K; CLARKE EA; WIKLUND T; STOTER G; GOSPODAROWICZ M; STURGEON J; FRAUMENI JF; BOICE JD
    RISK OF 2ND MALIGNANT NEOPLASMS AMONG LONG-TERM SURVIVORS OF TESTICULAR CANCER
    Journal of the National Cancer Institute
    
    L.B. Travis et al., "RISK OF 2ND MALIGNANT NEOPLASMS AMONG LONG-TERM SURVIVORS OF TESTICULAR CANCER", Journal of the National Cancer Institute, 89(19), 1997, pp. 1429-1439
57. PAWSON R; AHERN R; CATOVSKY D
    2ND MALIGNANCY IN HAIRY-CELL LEUKEMIA - NO EVIDENCE OF INCREASED INCIDENCE AFTER TREATMENT WITH INTERFERON-ALPHA
    Leukemia & lymphoma
    
    R. Pawson et al., "2ND MALIGNANCY IN HAIRY-CELL LEUKEMIA - NO EVIDENCE OF INCREASED INCIDENCE AFTER TREATMENT WITH INTERFERON-ALPHA", Leukemia & lymphoma, 22(1-2), 1996, pp. 103-106
58. MUNKER R; HILLER E; MELNYK A; GUTJAHR P
    2ND MALIGNANCIES - CLINICAL RELEVANCE AND BASIC RESEARCH (REVIEW)
    International journal of oncology
    
    R. Munker et al., "2ND MALIGNANCIES - CLINICAL RELEVANCE AND BASIC RESEARCH (REVIEW)", International journal of oncology, 9(4), 1996, pp. 763-776
59. OREILLY E; CROWN J
    2ND CANCERS COMPLICATING HODGKINS-DISEASE
    Annals of oncology
    
    E. Oreilly e J. Crown, "2ND CANCERS COMPLICATING HODGKINS-DISEASE", Annals of oncology, 7(4), 1996, pp. 405-408
60. RUBAGOTTI A; PERROTTA A; CASELLA C; BOCCARDO F
    RISK OF NEW PRIMARIES AFTER CHEMOTHERAPY AND OR TAMOXIFEN TREATMENT FOR EARLY BREAST-CANCER/
    Annals of oncology
    
    A. Rubagotti et al., "RISK OF NEW PRIMARIES AFTER CHEMOTHERAPY AND OR TAMOXIFEN TREATMENT FOR EARLY BREAST-CANCER/", Annals of oncology, 7(3), 1996, pp. 239-244
61. DIAMANDIDOU E; BUZDAR AU; SMITH TL; FRYE D; WITJAKSONO M; HORTOBAGYI GN
    TREATMENT-RELATED LEUKEMIA IN BREAST-CANCER PATIENTS TREATED WITH FLUOROURACIL-DOXORUBICIN-CYCLOPHOSPHAMIDE COMBINATION ADJUVANT CHEMOTHERAPY - THE UNIVERSITY-OF-TEXAS MD-ANDERSON-CANCER-CENTER EXPERIENCE
    Journal of clinical oncology
    
    E. Diamandidou et al., "TREATMENT-RELATED LEUKEMIA IN BREAST-CANCER PATIENTS TREATED WITH FLUOROURACIL-DOXORUBICIN-CYCLOPHOSPHAMIDE COMBINATION ADJUVANT CHEMOTHERAPY - THE UNIVERSITY-OF-TEXAS MD-ANDERSON-CANCER-CENTER EXPERIENCE", Journal of clinical oncology, 14(10), 1996, pp. 2722-2730
62. SETO Y; NAGAWA H; MUTO T
    TREATMENT OF MULTIPLE EARLY GASTRIC-CANCER
    Japanese Journal of Clinical Oncology
    
    Y. Seto et al., "TREATMENT OF MULTIPLE EARLY GASTRIC-CANCER", Japanese Journal of Clinical Oncology, 26(3), 1996, pp. 134-138
63. KARASEK K; DEUTSCH M
    LUMPECTOMY AND BREAST IRRADIATION FOR BREAST-CANCER AFTER RADIOTHERAPY FOR LYMPHOMA
    American journal of clinical oncology
    
    K. Karasek e M. Deutsch, "LUMPECTOMY AND BREAST IRRADIATION FOR BREAST-CANCER AFTER RADIOTHERAPY FOR LYMPHOMA", American journal of clinical oncology, 19(5), 1996, pp. 451-454
64. DENSMORE TL; LANGER JC; MOLLESTON JP; DEHNER LP; COFFIN CM
    COLORECTAL ADENOCARCINOMA AS A 2ND MALIGNANT NEOPLASM FOLLOWING WILMS-TUMOR AND RHABDOMYOSARCOMA
    Medical and pediatric oncology
    
    T.L. Densmore et al., "COLORECTAL ADENOCARCINOMA AS A 2ND MALIGNANT NEOPLASM FOLLOWING WILMS-TUMOR AND RHABDOMYOSARCOMA", Medical and pediatric oncology, 27(6), 1996, pp. 556-560
65. POLYCHRONOPOULOU S; PANAGIOTOU JP; PAPADAKIS T; MAVROU A; ANAGNOSTOU D; HAIDAS S
    SECONDARY MALIGNANCIES IN A CHILD WITH HODGKINS-DISEASE - PERIPHERAL T-CELL LYMPHOMA AND MYELODYSPLASTIC SYNDROME EVOLVING INTO ACUTE NONLYMPHOBLASTIC LEUKEMIA
    Medical and pediatric oncology
    
    S. Polychronopoulou et al., "SECONDARY MALIGNANCIES IN A CHILD WITH HODGKINS-DISEASE - PERIPHERAL T-CELL LYMPHOMA AND MYELODYSPLASTIC SYNDROME EVOLVING INTO ACUTE NONLYMPHOBLASTIC LEUKEMIA", Medical and pediatric oncology, 26(5), 1996, pp. 359-366
66. SEKINE I; NISHIWAKI Y; KAKINUMA R; KUBOTA K; HOJO F; MATSUMOTO T; OHMATSU H; YOKOZAKI M; GOTO K; KODAMA T
    LATE RECURRENCE OF SMALL-CELL LUNG-CANCER - TREATMENT AND OUTCOME
    Oncology
    
    I. Sekine et al., "LATE RECURRENCE OF SMALL-CELL LUNG-CANCER - TREATMENT AND OUTCOME", Oncology, 53(4), 1996, pp. 318-321
67. NISHIKUBO CY; KUNKEL LA; FIGLIN R; BELLDEGRUN A; ROSEN P; ELASHOFF R; WANG HJ; TERRITO MC
    AN ASSOCIATION BETWEEN RENAL-CELL CARCINOMA AND LYMPHOID MALIGNANCIES- A CASE SERIES OF 8 PATIENTS
    Cancer
    
    C.Y. Nishikubo et al., "AN ASSOCIATION BETWEEN RENAL-CELL CARCINOMA AND LYMPHOID MALIGNANCIES- A CASE SERIES OF 8 PATIENTS", Cancer, 78(11), 1996, pp. 2421-2426
68. TIHAN T; FILIPPA DA
    COEXISTENCE OF RENAL-CELL CARCINOMA AND MALIGNANT-LYMPHOMA - A CAUSALRELATIONSHIP OR COINCIDENTAL OCCURRENCE
    Cancer
    
    T. Tihan e D.A. Filippa, "COEXISTENCE OF RENAL-CELL CARCINOMA AND MALIGNANT-LYMPHOMA - A CAUSALRELATIONSHIP OR COINCIDENTAL OCCURRENCE", Cancer, 77(11), 1996, pp. 2325-2331
69. SORIA JC; FIZAZI K; MERAD M; LECHEVALIER T
    SYNDROME OF INAPPROPRIATE ANTIDIURETIC-HO RMONE SECRETION AS FIRST SIGN OF 2ND PRIMARY LUNG-CANCER 5 YEARS AFTER COMPLETE REMISSION OF A SMALL-CELL LUNG-CARCINOMA
    Bulletin du cancer
    
    J.C. Soria et al., "SYNDROME OF INAPPROPRIATE ANTIDIURETIC-HO RMONE SECRETION AS FIRST SIGN OF 2ND PRIMARY LUNG-CANCER 5 YEARS AFTER COMPLETE REMISSION OF A SMALL-CELL LUNG-CARCINOMA", Bulletin du cancer, 83(8), 1996, pp. 605-608
70. TALLMAN MS; GRAY R; BENNETT JM; VARIAKOJIS D; ROBERT N; WOOD WC; ROWE JM; WIERNIK PH
    LEUKEMOGENIC POTENTIAL OF ADJUVANT CHEMOTHERAPY FOR EARLY-STAGE BREAST-CANCER - THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP EXPERIENCE
    Journal of clinical oncology
    
    M.S. Tallman et al., "LEUKEMOGENIC POTENTIAL OF ADJUVANT CHEMOTHERAPY FOR EARLY-STAGE BREAST-CANCER - THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP EXPERIENCE", Journal of clinical oncology, 13(7), 1995, pp. 1557-1563
71. LASSEN U; OSTERLIND K; HANSEN M; DOMBERNOWSKY P; BERGMAN B; HANSEN HH
    LONG-TERM SURVIVAL IN SMALL-CELL LUNG-CANCER - POSTTREATMENT CHARACTERISTICS IN PATIENTS SURVIVING 5 TO 18- AN ANALYSIS OF 1,714 CONSECUTIVE PATIENTS( YEARS )
    Journal of clinical oncology
    
    U. Lassen et al., "LONG-TERM SURVIVAL IN SMALL-CELL LUNG-CANCER - POSTTREATMENT CHARACTERISTICS IN PATIENTS SURVIVING 5 TO 18- AN ANALYSIS OF 1,714 CONSECUTIVE PATIENTS( YEARS )", Journal of clinical oncology, 13(5), 1995, pp. 1215-1220
72. BEATY O; HUDSON MM; GREENWALD C; LUO XL; FANG L; WILIMAS JA; THOMPSON EI; KUN LE; PRATT CB
    SUBSEQUENT MALIGNANCIES IN CHILDREN AND ADOLESCENTS AFTER TREATMENT FOR HODGKINS-DISEASE
    Journal of clinical oncology
    
    O. Beaty et al., "SUBSEQUENT MALIGNANCIES IN CHILDREN AND ADOLESCENTS AFTER TREATMENT FOR HODGKINS-DISEASE", Journal of clinical oncology, 13(3), 1995, pp. 603-609
73. HILL M; MILAN S; CUNNINGHAM D; MANSI J; SMITH I; CATOVSKY D; GORE M; ZULIAN G; SELBY P; HORWICH A; OBRIEN M; NICOLSON M; HICKISH T
    EVALUATION OF THE EFFICACY OF THE VEEP REGIMEN IN ADULT HODGKINS-DISEASE WITH ASSESSMENT OF GONADAL AND CARDIAC TOXICITY
    Journal of clinical oncology
    
    M. Hill et al., "EVALUATION OF THE EFFICACY OF THE VEEP REGIMEN IN ADULT HODGKINS-DISEASE WITH ASSESSMENT OF GONADAL AND CARDIAC TOXICITY", Journal of clinical oncology, 13(2), 1995, pp. 387-395
74. HALL EJ; MARTIN SG; AMOLS H; HEI TK
    PHOTONEUTRONS FROM MEDICAL LINEAR ACCELERATORS - RADIOBIOLOGICAL MEASUREMENTS AND RISK ESTIMATES
    International journal of radiation oncology, biology, physics
    
    E.J. Hall et al., "PHOTONEUTRONS FROM MEDICAL LINEAR ACCELERATORS - RADIOBIOLOGICAL MEASUREMENTS AND RISK ESTIMATES", International journal of radiation oncology, biology, physics, 33(1), 1995, pp. 225-230
75. STURGIS EM; MILLER RH
    2ND PRIMARY MALIGNANCIES IN THE HEAD AND NECK-CANCER PATIENT
    The Annals of otology, rhinology & laryngology
    
    E.M. Sturgis e R.H. Miller, "2ND PRIMARY MALIGNANCIES IN THE HEAD AND NECK-CANCER PATIENT", The Annals of otology, rhinology & laryngology, 104(12), 1995, pp. 946-954
76. VANLEEUWEN FE; KLOKMAN WJ; STOVALL M; HAGENBEEK A; VANDENBELTDUSEBOUT AW; NOYON R; BOICE JD; BURGERS JMV; SOMERS R
    ROLES OF RADIOTHERAPY AND SMOKING IN LUNG-CANCER FOLLOWING HODGKINS-DISEASE
    Journal of the National Cancer Institute
    
    F.E. Vanleeuwen et al., "ROLES OF RADIOTHERAPY AND SMOKING IN LUNG-CANCER FOLLOWING HODGKINS-DISEASE", Journal of the National Cancer Institute, 87(20), 1995, pp. 1530-1537
77. TRAVIS LB; CURTIS RE; BENNETT WP; HANKEY BF; TRAVIS WD; BOICE JD
    LUNG-CANCER AFTER HODGKINS-DISEASE
    Journal of the National Cancer Institute
    
    L.B. Travis et al., "LUNG-CANCER AFTER HODGKINS-DISEASE", Journal of the National Cancer Institute, 87(17), 1995, pp. 1324-1327
78. SPIELBERGER RT; MICK R; RATAIN MJ; GOLOMB HM
    INTERFERON TREATMENT FOR HAIRY-CELL LEUKEMIA - AN UPDATE ON A COHORT OF 69 PATIENTS TREATED FROM 1983 TO 1986
    Leukemia & lymphoma
    
    R.T. Spielberger et al., "INTERFERON TREATMENT FOR HAIRY-CELL LEUKEMIA - AN UPDATE ON A COHORT OF 69 PATIENTS TREATED FROM 1983 TO 1986", Leukemia & lymphoma, 14, 1994, pp. 89-93
79. STEIN ME; KANTOR A; SPENCER D; BEZWODA WR
    CLASSICAL KAPOSIS-SARCOMA IN CAUCASIANS IN AFRICA EXPERIENCE AT THE JOHANNESBURG HOSPITAL (1978-1992)
    Dermatology
    
    M.E. Stein et al., "CLASSICAL KAPOSIS-SARCOMA IN CAUCASIANS IN AFRICA EXPERIENCE AT THE JOHANNESBURG HOSPITAL (1978-1992)", Dermatology, 188(3), 1994, pp. 182-187
80. HESS CF; KORTMANN RD; SCHMIDBERGER H; BAMBERG M
    HOW RELEVANT IS SECONDARY LEUKEMIA FOR INITIAL TREATMENT SELECTION INHODGKINS-DISEASE
    European journal of cancer
    
    C.F. Hess et al., "HOW RELEVANT IS SECONDARY LEUKEMIA FOR INITIAL TREATMENT SELECTION INHODGKINS-DISEASE", European journal of cancer, 30A(10), 1994, pp. 1441-1447
81. HESS CF; KORTMANN RD; SCHMIDBERGER H; BAMBERG M
    HOW RELEVANT IS SECONDARY LEUKEMIA FOR INITIAL TREATMENT SELECTION INHODGKINS-DISEASE
    European journal of cancer
    
    C.F. Hess et al., "HOW RELEVANT IS SECONDARY LEUKEMIA FOR INITIAL TREATMENT SELECTION INHODGKINS-DISEASE", European journal of cancer, 30A(10), 1994, pp. 1441-1447
82. CASTIGLIONE M; GOLDHIRSCH A
    2ND TUMORS AFTER BREAST-CANCER - IS IT STILL TOO SOON TO TELL
    Annals of oncology
    
    M. Castiglione e A. Goldhirsch, "2ND TUMORS AFTER BREAST-CANCER - IS IT STILL TOO SOON TO TELL", Annals of oncology, 5(9), 1994, pp. 785-787
83. VALAGUSSA P; MOLITERNI A; TERENZIANI M; ZAMBETTI M; BONADONNA G
    2ND MALIGNANCIES FOLLOWING CMF-BASED ADJUVANT CHEMOTHERAPY IN RESECTABLE BREAST-CANCER
    Annals of oncology
    
    P. Valagussa et al., "2ND MALIGNANCIES FOLLOWING CMF-BASED ADJUVANT CHEMOTHERAPY IN RESECTABLE BREAST-CANCER", Annals of oncology, 5(9), 1994, pp. 803-808
84. MELLEMGAARD A; GEISLER CH; STORM HH
    RISK OF KIDNEY CANCER AND OTHER 2ND SOLID MALIGNANCIES IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA
    European journal of haematology
    
    A. Mellemgaard et al., "RISK OF KIDNEY CANCER AND OTHER 2ND SOLID MALIGNANCIES IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA", European journal of haematology, 53(4), 1994, pp. 218-222
85. SHAPIRO CL; HENDERSON IC
    ADJUVANT THERAPY OF BREAST-CANCER
    Hematology/oncology clinics of North America
    
    C.L. Shapiro e I.C. Henderson, "ADJUVANT THERAPY OF BREAST-CANCER", Hematology/oncology clinics of North America, 8(1), 1994, pp. 213-231
86. ECONOMOPOULOS T; STATHAKIS N; ALEXOPOULOS C; PAVLIDIS N; CONSTANTINIDOU M; BRIASSOULIS E; PAPAGEORGIOU E; DERVENOULAS J; PAPPA V; VASLAMATZIS M; RAPTIS S
    2ND MALIGNANCIES FOLLOWING TREATMENT FOR HODGKINS-DISEASE - A GREEK EXPERIENCE
    Haematologica
    
    T. Economopoulos et al., "2ND MALIGNANCIES FOLLOWING TREATMENT FOR HODGKINS-DISEASE - A GREEK EXPERIENCE", Haematologica, 79(3), 1994, pp. 273-276
87. HAHN P; NELSON N; BARAL E
    LEUKEMIA IN PATIENTS WITH BREAST-CANCER FOLLOWING ADJUVANT CHEMOTHERAPY AND OR POSTOPERATIVE RADIATION-THERAPY/
    Acta oncologica
    
    P. Hahn et al., "LEUKEMIA IN PATIENTS WITH BREAST-CANCER FOLLOWING ADJUVANT CHEMOTHERAPY AND OR POSTOPERATIVE RADIATION-THERAPY/", Acta oncologica, 33(6), 1994, pp. 599-602
88. MORO D; JACOULET P; QUOIX E; RANFAING E; BRAMBILLA E; CAPRON F; LAGRANGE JL; MILLERON B; LEBEAU B; RUFFIE P; RIVIERE A; BLANCHON F; GERAADS A; DEPIERRE A
    SMALL-CELL LUNG-CANCER - PATIENTS SURVIVING LONGER THAN 30 MONTHS
    Anticancer research
    
    D. Moro et al., "SMALL-CELL LUNG-CANCER - PATIENTS SURVIVING LONGER THAN 30 MONTHS", Anticancer research, 14(1B), 1994, pp. 301-304
89. GASPARINI M; LOMBARDI F; BALLERINI E; GANDOLA L; GIANNI MC; MASSIMINO M; ROTTOLI L; FOSSATIBELLANI F
    LONG-TERM OUTCOME OF PATIENTS WITH MONOSTOTIC EWINGS-SARCOMA TREATED WITH COMBINED-MODALITY
    Medical and pediatric oncology
    
    M. Gasparini et al., "LONG-TERM OUTCOME OF PATIENTS WITH MONOSTOTIC EWINGS-SARCOMA TREATED WITH COMBINED-MODALITY", Medical and pediatric oncology, 23(5), 1994, pp. 406-412
90. HAGEMEISTER FB; PURUGGANAN R; FULLER L; MCLAUGHLIN P; SWAN F; ROMAGUERA J; RODRIGUEZ M; CABANILLAS F
    TREATMENT OF EARLY STAGES OF HODGKINS-DISEASE WITH NOVANTRONE, VINCRISTINE, VINBLASTINE, PREDNISONE, AND RADIOTHERAPY
    Seminars in hematology
    
    F.B. Hagemeister et al., "TREATMENT OF EARLY STAGES OF HODGKINS-DISEASE WITH NOVANTRONE, VINCRISTINE, VINBLASTINE, PREDNISONE, AND RADIOTHERAPY", Seminars in hematology, 31(2), 1994, pp. 36-43
91. BREUER CK; TARBELL NJ; MAUCH PM; WEINSTEIN HJ; MORRISSEY M; NEUBERG D; SHAMBERGER RC
    THE IMPORTANCE OF STAGING LAPAROTOMY IN PEDIATRIC HODGKINS-DISEASE
    Journal of pediatric surgery
    
    C.K. Breuer et al., "THE IMPORTANCE OF STAGING LAPAROTOMY IN PEDIATRIC HODGKINS-DISEASE", Journal of pediatric surgery, 29(8), 1994, pp. 1085-1089
92. KAMPMEIER P; SPIELBERGER R; DICKSTEIN J; MICK R; GOLOMB H; VARDIMAN JW
    INCREASED INCIDENCE OF 2ND NEOPLASMS IN PATIENTS TREATED WITH INTERFERON-ALPHA-2B FOR HAIRY-CELL LEUKEMIA - A CLINICOPATHOLOGICAL ASSESSMENT
    Blood
    
    P. Kampmeier et al., "INCREASED INCIDENCE OF 2ND NEOPLASMS IN PATIENTS TREATED WITH INTERFERON-ALPHA-2B FOR HAIRY-CELL LEUKEMIA - A CLINICOPATHOLOGICAL ASSESSMENT", Blood, 83(10), 1994, pp. 2931-2938
93. ROBINSON BA; COLLS BM; FITZHARRIS BM; ATKINSON CH
    2ND MALIGNANT NEOPLASMS IN PATIENTS WITH HODGKINS-DISEASE
    Australian and New Zealand Journal of Medicine
    
    B.A. Robinson et al., "2ND MALIGNANT NEOPLASMS IN PATIENTS WITH HODGKINS-DISEASE", Australian and New Zealand Journal of Medicine, 24(4), 1994, pp. 368-373
94. GIACCHETTI S; RAOUL Y; WIBAULT P; DROZ JP; COURT B; ESCHWEGE F
    TREATMENT OF STAGE-I TESTIS SEMINOMA BY RADIOTHERAPY - LONG-TERM RESULTS - A 30-YEAR EXPERIENCE
    International journal of radiation oncology, biology, physics
    
    S. Giacchetti et al., "TREATMENT OF STAGE-I TESTIS SEMINOMA BY RADIOTHERAPY - LONG-TERM RESULTS - A 30-YEAR EXPERIENCE", International journal of radiation oncology, biology, physics, 27(1), 1993, pp. 3-9
95. SCHOENTHALER R; CASTRO JR; HALBERG FE; PHILLIPS TL
    DEFINITIVE POSTOPERATIVE IRRADIATION OF BILE-DUCT CARCINOMA WITH CHARGED-PARTICLES AND OR PHOTONS
    International journal of radiation oncology, biology, physics
    
    R. Schoenthaler et al., "DEFINITIVE POSTOPERATIVE IRRADIATION OF BILE-DUCT CARCINOMA WITH CHARGED-PARTICLES AND OR PHOTONS", International journal of radiation oncology, biology, physics, 27(1), 1993, pp. 75-82
96. ZEMLICKIS D; LISHNER M; ERLICH R; KOREN G
    TERATOGENICITY AND CARCINOGENICITY IN A TWIN EXPOSED IN-UTERO TO CYCLOPHOSPHAMIDE
    Teratogenesis, carcinogenesis, and mutagenesis
    
    D. Zemlickis et al., "TERATOGENICITY AND CARCINOGENICITY IN A TWIN EXPOSED IN-UTERO TO CYCLOPHOSPHAMIDE", Teratogenesis, carcinogenesis, and mutagenesis, 13(3), 1993, pp. 139-143
97. MAUCH PM; FERRY JA; BHALLA M; CAREY RW; SPITZER TR
    A 39-YEAR-OLD MAN WITH BILATERAL RENAL MASSES A FEW MONTHS AFTER TREATMENT FOR HODGKINS-DISEASE, STAGE-IIA - MALIGNANT-LYMPHOMA, DIFFUSE LARGE-CELL TYPE, B-LINEAGE, OF KIDNEYS, AFTER HODGKINS-DISEASE, NODULAR-SCLEROSIS TYPE
    The New England journal of medicine
    
    P.M. Mauch et al., "A 39-YEAR-OLD MAN WITH BILATERAL RENAL MASSES A FEW MONTHS AFTER TREATMENT FOR HODGKINS-DISEASE, STAGE-IIA - MALIGNANT-LYMPHOMA, DIFFUSE LARGE-CELL TYPE, B-LINEAGE, OF KIDNEYS, AFTER HODGKINS-DISEASE, NODULAR-SCLEROSIS TYPE", The New England journal of medicine, 328(19), 1993, pp. 1406-1414
98. ZORLU AF; ATAHAN IL; GEDIKOGLU G; RUACAN S; SAYEK I; TEKUZMAN G
    DOES GASTRIC ADENOCARCINOMA DEVELOP AFTER THE TREATMENT OF GASTRIC LYMPHOMA
    Journal of surgical oncology
    
    A.F. Zorlu et al., "DOES GASTRIC ADENOCARCINOMA DEVELOP AFTER THE TREATMENT OF GASTRIC LYMPHOMA", Journal of surgical oncology, 54(2), 1993, pp. 126-131
99. MARK RJ; BAILET JW; POEN J; TRAN LM; CALCATERRA TC; ABEMAYOR E; FU YS; PARKER RG
    POSTIRRADIATION SARCOMA OF THE HEAD AND NECK
    Cancer
    
    R.J. Mark et al., "POSTIRRADIATION SARCOMA OF THE HEAD AND NECK", Cancer, 72(3), 1993, pp. 887-893